过氧化物酶体增殖物激活受体α抑制迟发型Fuchs内皮性角膜营养不良中异常细胞外基质积聚并维持能量代谢
研究基于GSE171830基因集富集分析发现FECD组线粒体脂肪酸β氧化与三羧酸循环过程负富集,并在UV-A诱导的迟发型FECD老年小鼠模型中观察到PPARα敲除小鼠角膜混浊、水肿及内皮细胞形态改变更明显。激活或过表达PPARα可减轻角膜内皮损伤、逆转Descemet膜增厚并下调纤维化相关基因,非诺贝特可逆转TGF-β诱导的纤维化与线粒体损伤。作者认为PPARα可能是延缓FECD进展的潜在靶点。
要点
- FECD组线粒体脂肪酸β氧化与三羧酸循环过程呈负富集,FAO通路代谢物在PPARα敲除小鼠角膜中减少。
- UV-A照射后老年PPARα敲除小鼠较野生型角膜混浊、水肿更重,内皮细胞形态改变更明显。
- 激活或过表达PPARα可减轻角膜内皮损伤、逆转Descemet膜增厚并下调αSMA与Col1a。
核心结论
- 作者提出过表达或激活PPARα可抑制角膜内皮脂肪酸β氧化能量功能障碍及Descemet膜异常细胞外基质形成,PPARα可能是减缓FECD进展的潜在靶点。
研究设计与样本
- 基于GSE171830数据集进行基因集富集分析与基因集变异分析。
- 建立UV-A诱导的迟发型FECD老年小鼠模型,比较老年PPARα敲除小鼠与野生型小鼠。
- 采用质谱检测老年PPARα敲除小鼠与野生型小鼠角膜总代谢物。
- 在B4G12细胞系中进行小干扰PPARα及体外实验。
主要发现
- GSE171830中FECD组线粒体脂肪酸β氧化与三羧酸循环过程负富集,且FAO相关酶减少。
- UV-A照射后老年PPARα敲除小鼠较野生型角膜混浊、角膜水肿及角膜内皮细胞形态改变更明显。
- 老年PPARα敲除小鼠角膜中FAO通路代谢物减少。
- 基因集变异分析显示FAO能量代谢评分与TGF-β通路评分呈负相关。
- 老年PPARα敲除小鼠及小干扰PPARα的B4G12细胞中αSMA与Col1a表达增加。
关键数值与推荐
- 照射后激活或过表达PPARα可减少角膜内皮损伤并逆转Descemet膜增厚,同时下调αSMA与Col1a等纤维化相关基因。
- 体外实验显示非诺贝特可逆转TGF-β诱导的纤维化及细胞间连接损伤。
- 非诺贝特可减轻B4G12细胞线粒体损伤并提高TGF-β处理后的耗氧率。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Fuchs endothelial corneal dystrophy (FECD) is the most common corneal endothelial dystrophy and guttae are crucial in causing progressive loss of corneal endothelium. This study aimed to find a way to inhibit the formation of guttae in FECD. METHODS AND RESULTS: Mitochondria fatty acid β-oxidation (FAO) and tricarboxylic acid (TCA) cycle processes were negatively enriched in the FECD group according to gene set enrichment analysis in GSE171830. In vivo UV-A-induced late-onset FECD mouse model were established. After irradiation, aged proliferator-activated receptor alpha (PPARα-/-) mice manifested greater corneal opacity, cornea edema, and varied corneal endothelial cell morphology compared with wild-type mice. The total metabolites in cornea of aged PPARα-/- mice and wild-type mice were detected by mass spectrometry. Metabolites of the FAO pathway were decreased in corneas of PPARα-/- mice, coincident with enzymes of FAO decreased in GSE171830. The score for FAO energy metabolism was negatively related to that of the TGF-β pathway according to gene set variation analysis. The express of alpha smooth muscle actin (αSMA) and Col1a were increased in aged PPARα-/- mice and small interfering PPARα B4G12 cell lines. After irradiation, activation or overexpression of PPARα demonstrated reduced corneal endothelial damage and reversal of Descemet membrane thickening, along with downregulation of fibrosis-related genes such as αSMA and collagen type I alpha 1 (Col1a). In vitro experiments revealed that fenofibrate could reverse fibrosis and damage of cell-to-cell connections induced by TGF-β. Additionally, fenofibrate was found to alleviate mitochondrial damage in B4G12 and increase oxygen consumption rates after TGF-β treatment. CONCLUSIONS: Overall, we suggested that the overexpression or activation of PPARα can inhibit FAO energy dysfunction of corneal endothelium and the abnormal extracellular matrix formation in Descemet's membrane, which is the primary pathology of FECD. Thus, PPARα may be a potential target for attenuating the progression of FECD.
引用
- Li X, Liu A, Zhou Y, et al. Proliferator-Activated Receptor Alpha Inhibits Abnormal Extracellular Matrix Accumulation and Maintains Energy Metabolism in Late-Onset Fuchs Endothelial Corneal Dystrophy. Invest Ophthalmol Vis Sci. 2025. PMID: 40232711. doi:10.1167/iovs.66.4.36
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。